NASDAQ:AGTC Applied Genetic Technologies (AGTC) Stock Price, News & Analysis → The ONE AI sSock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free AGTC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.39▼$0.3950-Day Range$0.37▼$0.4252-Week Range$0.23▼$2.83VolumeN/AAverage Volume943,490 shsMarket Capitalization$26.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Applied Genetic Technologies alerts: Email Address Ad Weiss RatingsThe ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. About Applied Genetic Technologies Stock (NASDAQ:AGTC)Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.Read More Ad Porter & CompanyUrgent new message from Porter StansberryI’ve been in the financial markets for close to three decades… Yet, I’ve never seen an opportunity that’s so urgent, so critical, and yet so overlooked than what is unfolding right now. You see, in one corner of the markets a financial anomaly has emerged that promises to be the single most important story of 2024.Click here now to get what could be the most urgent, and most lucrative research, my team has ever r AGTC Stock News HeadlinesFebruary 8, 2024 | finance.yahoo.comBeacon Therapeutics Announces Positive 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis PigmentosaJanuary 5, 2024 | marketwatch.comMetagenomi Technologies Files for Initial Public OfferingMarch 19, 2024 | Banyan Hill Publishing (Ad)AI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… December 18, 2023 | msn.comA new mathematical language for biological networksOctober 23, 2023 | investing.comGenetic Technologies (GENE) Earnings Dates & ReportsJune 12, 2023 | lse.co.ukSyncona launches new gene therapy company with GBP96 million fundingJune 1, 2023 | msn.comNew AI tool searches genetic haystacks to find disease-causing variantsMay 17, 2023 | uk.finance.yahoo.comSania Therapeutics launches to advance novel medicines for neural circuit dysfunctionMarch 19, 2024 | Banyan Hill Publishing (Ad)AI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… May 1, 2023 | usnews.comApplied Technology CenterApril 27, 2023 | finance.yahoo.comAAV Vectors in Gene Therapy Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 70+ Companies Working in the DomainApril 21, 2023 | msn.comWorld-first technology from biomodal enables reading of genetic and epigenetic information using existing sequencersApril 1, 2023 | nbcnews.comElephant in the dining room: Startup creates mammoth meatballMarch 22, 2023 | bbc.co.ukGenetic control of metabolismMarch 16, 2023 | bbc.co.ukGenetic testing and cystic fibrosisJanuary 31, 2023 | yahoo.comRallybio Announces Appointment of Jonathan I. Lieber as Chief Financial OfficerJanuary 5, 2023 | thestreet.comApplied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen DealNovember 28, 2022 | finance.yahoo.com*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*November 22, 2022 | finance.yahoo.com*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER*November 15, 2022 | finance.yahoo.comApplied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022November 3, 2022 | finance.yahoo.comApplied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022October 25, 2022 | finance.yahoo.comFlorida investment firm looks to take Cambridge gene therapy startup privateOctober 24, 2022 | lse.co.ukSyncona to acquire retinal therapy firm Applied Genetic TechnologiesOctober 23, 2022 | finance.yahoo.comSyncona to Acquire Applied Genetic Technologies CorporationOctober 18, 2022 | markets.businessinsider.comiNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesisSeptember 30, 2022 | msn.comHC Wainwright & Co. Maintains Buy Rating for Applied Genetic: Here's What You Need To KnowSeptember 23, 2022 | fool.comApplied Genetic Technologies (NASDAQ: AGTC)See More Headlines Receive AGTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2021Today3/18/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:AGTC CUSIPN/A CIK1273636 Webwww.agtc.com Phone(386) 462-2204FaxN/AEmployees83Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-68,940,000.00 Net MarginsN/A Pretax Margin-21,537.54% Return on Equity-192.90% Return on Assets-92.54% Debt Debt-to-Equity Ratio0.39 Current Ratio1.40 Quick Ratio1.40 Sales & Book Value Annual Sales$320,000.00 Price / Sales83.19 Cash FlowN/A Price / Cash FlowN/A Book Value$0.26 per share Price / Book1.51Miscellaneous Outstanding Shares67,632,000Free Float64,859,000Market Cap$26.62 million OptionableOptionable Beta1.55 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Susan B. Washer (Age 61)Pres, CEO & Director Comp: $747.84kMr. Jonathan I. Lieber M.B.A. (Age 52)Chief Financial Officer Comp: $533.14kDr. Susan Schneider M.D. (Age 64)Chief Medical Officer Comp: $480.32kDr. Nicholas MuzyczkaCo-FounderDr. Barry J. Byrne M.D.Ph.D., Co-FounderDr. William W. HauswirthCo-Founder & Member of Ophthalmology Scientific Advisory BoardDr. Richard Jude Samulski Ph.D.Co-FounderDr. Terence R. Flotte M.D.Co-FounderMr. Gerald Anthony ReynoldsChief Accounting Officer, Principal Accounting Officer & TreasurerDr. Abraham Scaria Ph.D. (Age 63)Chief Scientific Officer More ExecutivesKey CompetitorsSurrozenNASDAQ:SRZNZIVO BioscienceNASDAQ:ZIVOAptose BiosciencesNASDAQ:APTOSAB BiotherapeuticsNASDAQ:SABSMiNK TherapeuticsNASDAQ:INKTView All Competitors AGTC Stock Analysis - Frequently Asked Questions How were Applied Genetic Technologies' earnings last quarter? Applied Genetic Technologies Co. (NASDAQ:AGTC) released its quarterly earnings results on Tuesday, November, 9th. The biotechnology company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.35) by $0.05. During the same quarter in the previous year, the company earned ($0.60) earnings per share. What other stocks do shareholders of Applied Genetic Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Genetic Technologies investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Micron Technology (MU), VBI Vaccines (VBIV), Amarin (AMRN), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Anavex Life Sciences (AVXL), Galmed Pharmaceuticals (GLMD) and Genocea Biosciences (GNCA). This page (NASDAQ:AGTC) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Genetic Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.